All In Biotech

Free tool

FAERS Monitor: Cetirizine Hydrochloride Allergy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022429 or its brand name (Cetirizine Hydrochloride Allergy, Cetirizine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

79,983

Serious

60,044

75% of reports

Hospitalization

25,302

Death reported

9,000

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective13,781
  • fatigue13,767
  • pain12,748
  • rash10,518
  • off label use10,250
  • abdominal discomfort9,800
  • alopecia9,656
  • rheumatoid arthritis9,145
  • systemic lupus erythematosus8,883
  • pemphigus8,676
  • swelling8,337
  • hypersensitivity8,238
  • glossodynia8,162
  • headache8,142
  • pruritus8,137

Reports by year received

View as table
YearReports
2004244
2005246
2006202
2007278
2008491
2009436
2010488
2011772
2012958
2013989
20141,485
20152,185
20163,341
20173,253
20184,187
20195,111
20206,163
20218,587
20228,097
20237,366
20249,149
20259,499
20266,456

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,974,176 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pemphigusSignal8,676592.8571.11,572,793
glossodyniaSignal8,162150.2146.3769,991
systemic lupus erythematosusSignal8,88387.485.4570,052
swellingSignal8,33725.625.1180,443
rheumatoid arthritisSignal9,14522.922.5177,462
abdominal discomfortSignal9,80016.315.9133,141
alopeciaSignal9,65613.513.3107,684
hypersensitivitySignal8,23812.211.981,385
rashSignal10,5186.56.448,542
pruritusSignal8,1375.75.531,175
painSignal12,7485.65.547,984
fatigueSignal13,7674.74.641,112
headacheSignal8,1423.43.414,385
off label useSignal10,2503.13.015,062
drug ineffectiveSignal13,7812.82.716,430

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.